Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 138.70% | 233.85% | 136.72% | 9.50% | -46.27% |
| Total Depreciation and Amortization | 1.43% | 29.73% | 79.81% | 149.55% | 529.12% |
| Total Amortization of Deferred Charges | 31.62% | 67.68% | 160.66% | 595.45% | -- |
| Total Other Non-Cash Items | -57.08% | -125.87% | -103.02% | -2,916.13% | -53.85% |
| Change in Net Operating Assets | -112.12% | -83.22% | -41.62% | 304.77% | 323.00% |
| Cash from Operations | 28.07% | 40.77% | 52.08% | 128.50% | 23.93% |
| Capital Expenditure | 99.95% | 99.97% | 99.97% | 99.99% | -49,607.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 98.98% | 99.30% | 99.91% | 100.05% | -49,607.45% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -65.08% | -14,244.48% | -15,052.79% | -13,613.07% | -12,465.57% |
| Issuance of Common Stock | 477.27% | 173.75% | 41.45% | -69.67% | -85.56% |
| Repurchase of Common Stock | -51.10% | -- | -2,957.39% | 29.45% | 60.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 87.69% | -- |
| Cash from Financing | -227.17% | -215.55% | -202.99% | -189.85% | 536.46% |
| Foreign Exchange rate Adjustments | -376.58% | 166.08% | 160.18% | -176.83% | 166.87% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 93.92% | 21.98% | 52.96% | 96.62% | -414.66% |